The FDA said Monday it expanded the approval of Veklury to include pediatric patients in certain circumstances.
Previously, Veklury was only approved for children 12 under an emergency use authorization.
“As COVID-19 can cause severe illness in children, some of whom do not currently have a vaccination option, there continues to be a need for safe and effective COVID-19 treatment options for this population,” “Today’s approval of the first COVID-19 therapeutic for this population demonstrates the agency’s commitment to that need.”. President Donald Trump notably received the treatment after he tested positive for COVID-19.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA approves COVID drug for children, China deals with uphill COVID battle, and more COVID newsThe US Food and Drug Administration announced Monday that it has expanded approval of the COVID-19 drug remdesivir to treat patients as young as 28 days old. Here's that and more COVID news.
Lire la suite »
FDA approves first COVID-19 treatment for children under 12 years oldThe FDA gave approval to the use of Veklury (remdesivir) for children 28 days and older who weigh at least 3 kilograms (about 7 pounds).
Lire la suite »
FDA approves Remdesivir to treat COVID in young childrenThe antiviral drug is given as an injection. It was previously approved for patients 12 years of age and older.
Lire la suite »
FDA approves Remdesivir to treat COVID in young childrenThe antiviral drug is given as an injection. It was previously approved for patients 12 years of age and older.
Lire la suite »
FDA Faces Push to Loosen Rules for Sperm DonationsThe FDA relaxed its rules regarding blood donation by men who have sex with men. Now the agency is being asked to change its sperm donation rules.
Lire la suite »
FDA approves first COVID-19 treatment for children under 12 years oldThe FDA gave approval to the use of Veklury (remdesivir) for children 28 days and older who weigh at least 3 kilograms (about 7 pounds).
Lire la suite »